Skip Navigation



Cardiovascular Research Advance Access [Accepted Manuscript] published online on April 29, 2008

Cardiovascular Research, doi:10.1093/cvr/cvn112
This Article
Right arrow FREE Full Text (PDF) Freely available
Right arrow Supplementary Data
Right arrow All Versions of this Article:
79/3/509    most recent
cvn112v2
cvn112v1
Right arrow E-letters: Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when E-letters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrowRequest Permissions
Right arrow Disclaimer
Google Scholar
Right arrow Articles by Wang, H.-H.
Right arrow Articles by Yeh, H.-I
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Wang, H.-H.
Right arrow Articles by Yeh, H.-I
Social Bookmarking
 Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?

Published on behalf of the European Society of Cardiology. All rights reserved. © The Author 2008. For permissions please email: journals.permissions@oxfordjournals.org

Activation of endothelial cells to pathological status by down-regulation of connexin43

Hsueh-Hsiao Wanga, Chang-I Kunga, Yuen-Yi Tsenga, Yi-Chun Lina, Chi-Hau Chena, Cheng-Ho Tsaib,c,d and Hung-I Yehb,c,d,*

a Departments of Medical Research, Mackay Memorial Hospital, Taipei, Taiwan
b Departments of Internal Medicine, Mackay Memorial Hospital, Taipei, Taiwan
c Mackay Medicine, Nursing and Management College, Taipei, Taiwan
d Taipei Medical University, Taipei, Taiwan

* Corresponding author. Internal Medicine, Mackay Memorial Hospital, 92, Sec 2, Chung San North Road, Taipei 10449, Taiwan. Tel.: +886 2 25433535; Fax: +886 2 25433642. E-mail hiyeh{at}ms1.mmh.org.tw

Aims: We investigated the effects of connexin43 (Cx43) down-regulation on endothelial function.

Methods: We used 2 different sequences of Cx43-specific siRNA to reduce de novo synthesis of Cx43 in human aortic endothelial cells and then examined the expression profiles, proliferation activity and viability, and angiogenic potential. The involvement of mitogen-activated protein (MAP) kinase signaling pathways was analyzed. In parallel, the effect of inhibition of gap-junctional communication by connexin–mimetic peptides was evaluated.

Results: During the down-regulation of Cx43 by the siRNA, the cells exhibited impaired gap-junctional communication, proliferation, viability, and angiogenic potential. In addition, plasminogen activator inhibitor 1 (PAI-1) and von Willebrand factor were up-regulated. Furthermore, c-jun N-terminal kinase (JNK) and its downstream target c-jun were activated, while caspase-3, p38, and extracellular signal-regulated kinase (ERK) remained unchanged. Inhibition of JNK by SP600125 blocked the siRNA-induced increased expression of PAI-1 and partially recovered the impaired angiogenic potential. Short-term inhibition of Cx43 channels by connexin–mimetic peptides did not activate JNK.

Conclusions: Down-regulation of Cx43 inhibits gap-junctional communication and activates endothelial cells to pathological status, as characterized by up-regulation of coagulatory molecules and impairment of proliferation, viability, and angiogenesis. The processes are associated with activation of JNK signaling pathways and rectified by inhibition of the activation. These results suggest that inadequate expression of Cx43 per se impairs endothelial function via the activation of stress-activated protein kinase.


Time for primary review: 23 days


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?


This article has been cited by other articles:


Home page
Cardiovasc ResHome page
K. Inoue and Z.-G. Xiong
Silencing TRPM7 promotes growth/proliferation and nitric oxide production of vascular endothelial cells via the ERK pathway
Cardiovasc Res, August 1, 2009; 83(3): 547 - 557.
[Abstract] [Full Text] [PDF]



Disclaimer: Please note that abstracts for content published before 1996 were created through digital scanning and may therefore not exactly replicate the text of the original print issues. All efforts have been made to ensure accuracy, but the Publisher will not be held responsible for any remaining inaccuracies. If you require any further clarification, please contact our Customer Services Department.